Neoepitope Peptides Formulated in Immunovaccine's DepoVax(TM) Vaccine Platform Show Significant Positive Results in Preclinical Studies
November 03, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Appoints Gabriela Rosu, M.D., as Company's First Chief Medical Officer
November 01, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Nov. 1, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
October 13, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 13, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Positive Preclinical Data for Immunovaccine's DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress Europe
October 11, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 11, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 BIO Investor Forum
October 06, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 6, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...
Immunovaccine Announces Transition of Chief Financial Officer Role
October 03, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Oct. 3, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences
September 23, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 23, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
Immunovaccine to Present Pre-Clinical Data at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival
September 20, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 20, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical-stage vaccine and immunotherapy company,...
Immunovaccine Announces Dosing of First Patient in Phase 1b Clinical Trial for DPX-Survivac in Combination With Incyte's IDO1 Enzyme Inhibitor Epacadostat
September 08, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 8, 2016) - Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX:IMV)(OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company,...
Immunovaccine to Present at 2016 Rodman & Renshaw Global Investment Conference
September 01, 2016 07:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 1, 2016) - Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage vaccine and immunotherapy company, today announced that it will...